AstraZeneca Loses Patent Fight (AZN)
Late last Friday, drug maker AstraZeneca PLC (NYSE: AZN) lost its court fight to prevent a generic version of its anti-psychotic drug Seroquel from reaching the US market. The company ...Read Full Story »
Posts related to ‘patent protection’
Read Full Story »
-
Categories:
- 24/7 Wall St. Wire (9924)
- Accounting (510)
- Active Trader (4399)
- Aerospace & Defense (230)
- Alternative Energy (1059)
- Analyst Calls (5073)
- Autos (1473)
- Banking & Finance (3790)
- Bankruptcy (282)
- Buffett (339)
- Calendar (421)
- Casinos & Hotels (99)
- Commodities & Metals (1360)
- Consumer Product (795)
- Corporate Governance (1990)
- Dividends & Buybacks (923)
- Earnings (4146)
- Economy (3696)
- Editor's Picks (516)
- ETFs & Mutual Funds (822)
- General (3836)
- Healthcare (1433)
- Housing (1035)
- Industrials (630)
- Infrastructure (601)
- International Markets (4169)
- Internet (2194)
- IPOs & Secondaries (1650)
- Jobs (158)
- Labor (655)
- Media (4202)
- Mergers & Acquisitions (2226)
- Oil & Gas (2573)
- Personal Finance (305)
- Politics (822)
- Polls (34)
- Regulation (1162)
- Retail (2582)
- Rumors (1093)
- Services (297)
- Special Report (375)
- Technology (3821)
- Telecom & Wireless (1691)
- Transportation (581)
- Value Investing (763)
